拉贝洛尔协同治疗对妊娠期高血压患者妊娠结局影响及疗效评价

Effect of co-treatment with labetalol on pregnancy outcomes in patients with hypertension during pregnancy and its curative effect evaluation

目的:探讨拉贝洛尔协同治疗对妊娠期高血压患者妊娠结局影响及疗效评价。方法:2018年3月-2019年5月收治妊娠期高血压疾病患者124例,分为两组,各62例。常规组采用硫酸镁治疗;研究组采用拉贝洛尔协同治疗。比较两组疗效与妊娠结局。结果:研究组总有效率优于常规组,剖宫产、产后出血、胎儿宫内窘迫及新生儿窒息发生率均低于常规组,差异均有统计学意义(P<0.05)。结论:拉贝洛尔协同治疗妊娠期高血压疾病可显著增强临床疗效,改善分娩结局。

Objective:To explore the effect and clinical effect of labetalol on pregnancy outcome in patients with hypertension during pregnancy.Methods:124 patients with pregnancy induced hypertension were selected from March 2018 to May 2019,they were divided into the two groups with 62 cases in each group.The routine group was treated with magnesium sulfate,the study group was treated with labetalol co-treatment.The effect and pregnancy outcome of the two groups were compared.Results:The total effective rate of the study group was better than that of the conventional group,the incidence of cesarean section,postpartum hemorrhage,fetal distress and neonatal asphyxia in the study group were lower than that in the control group,the differences were statistically significant(P<0.05).Conclusion:Labetalol can significantly enhance the clinical efficacy and improve the delivery outcome in the treatment of pregnancy induced hypertension.